دورية أكاديمية

Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial

التفاصيل البيبلوغرافية
العنوان: Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial
المؤلفون: Kilburn, Lindsay B.Aff1, IDs41591024029101_cor1, Khuong-Quang, Dong-Anh, Hansford, Jordan R.Aff3, Aff4, Landi, Daniel, van der Lugt, Jasper, Leary, Sarah E. S., Driever, Pablo Hernáiz, Bailey, Simon, Perreault, Sébastien, McCowage, Geoffrey, Waanders, Angela J., Ziegler, David S.Aff13, Aff14, Aff15, Witt, OlafAff16, Aff17, Aff18, Aff19, Aff20, Baxter, Patricia A., Kang, Hyoung Jin, Hassall, Timothy E., Han, Jung Woo, Hargrave, Darren, Franson, Andrea T., Yalon Oren, Michal, Toledano, Helen, Larouche, Valérie, Kline, Cassie, Abdelbaki, Mohamed S., Jabado, Nada, Gottardo, Nicholas G., Gerber, Nicolas U., Whipple, Nicholas S., Segal, Devorah, Chi, Susan N., Oren, Liat, Tan, Enrica E. K., Mueller, Sabine, Cornelio, Izzy, McLeod, Lisa, Zhao, Xin, Walter, Ashley, Da Costa, Daniel, Manley, Peter, Blackman, Samuel C., Packer, Roger J., Nysom, Karsten
المصدر: Nature Medicine. 30(5):1500-1500
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:10788956
1546170X
DOI:10.1038/s41591-024-02910-1